Medtronic is struggling against Edwards Lifesciences in the companies' U.S. battles over transcatheter heart valve patents. But the Minnesota device giant's fortunes in Europe in the bitter fight have taken a significant turn for the better.
Medtronic has revealed details about the mounting legal troubles it faces concerning its Infuse bone growth spinal implant. About 700 lawsuits involving 1,000 personal injury cases are now pending over the controversial product, according to a recent regulatory filing.
Medtronic and Abbott have collaborated on a discount deal that makes the two stent giants preferred vendors for the costly medical devices at 135 U.S. hospitals.
Medtronic said it has implanted its new supersmall leadless pacemaker in its first U.S. patient as part of a global clinical trial of the device. This comes a few weeks after rival St. Jude Medical hit the same milestone with its own competing product.
Medtronic scored both a CE mark and FDA 510(k) clearance for a super-small wireless cardiac monitoring device-implant, and the Minnesota device giant is now pursuing a global rollout.
On Tuesday morning, Medtronic reported that its third quarter net earnings sank to $762 million, taking a 23% hit due in large part to setbacks in its renal denervation program and tax changes affecting the med tech industry.
Medtronic launched a new crossing catheter in Europe to treat peripheral artery disease. The device recently received a European CE mark, but has yet to win FDA clearance, the company said in a statement.
Any industry that's undergoing as much change as biopharma is always looking for leadership. Old marketing practices are being blown apart, R&D is being subjected to emergency surgery, drug...
It's a story that could confirm the worst fears of med tech implant wearers at the highest level of U.S. government: Some time during the first half of 2013, hackers reportedly broke into the computer networks of the big three medical device makers, and the breach might have stayed open for "several months."
Medtronic has failed to prevent another lawsuit involving its Infuse bone growth spinal implant from advancing. It's an ominous sign as the Minnesota device giant gears up for a growing number of related cases that are working their way through the court system.